Testing RUPISTAR in adults with advanced breast cancer that has an ESR1 mutation

Tests RUPISTAR in adults with advanced, hormone-sensitive breast cancer with an ESR1 mutation.

Plain-language title generated from the registry record
Registry title: RUPISTAR: A Study in patients with ER-positive, HER2-negative advanced breast cancer with ESR1 mutation

Key facts

Where

Lyon and Saint-Herblain Cedex, FranceSee the 2 sites

Phase

Phase 1